ID
43587
Description
Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00500500
Link
https://clinicaltrials.gov/show/NCT00500500
Keywords
Versions (2)
- 4/17/16 4/17/16 -
- 9/20/21 9/20/21 -
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Alzheimer Disease NCT00500500
Eligibility Alzheimer Disease NCT00500500
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
concomitant medication
Data type
boolean
Alias
- UMLS CUI [1]
- C2347852
Description
vitamin b12 level; folate
Data type
boolean
Alias
- UMLS CUI [1]
- C0202252
- UMLS CUI [2]
- C0523631
Description
pulmonary illness; cardiovascular illness; cancer; neurological illness; blood disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0024115
- UMLS CUI [2]
- C0007222
- UMLS CUI [3]
- C0006826
- UMLS CUI [4]
- C0027765
- UMLS CUI [5]
- C0018939
Similar models
Eligibility Alzheimer Disease NCT00500500
- StudyEvent: Eligibility
C0001779 (UMLS CUI [1,2])
C0038454 (UMLS CUI [2])
C2828081 (UMLS CUI [2])
C0523631 (UMLS CUI [2])
C0007222 (UMLS CUI [2])
C0006826 (UMLS CUI [3])
C0027765 (UMLS CUI [4])
C0018939 (UMLS CUI [5])